Erythropoietin (Epoplus)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameErythropoietin (Epoplus)

Drug Alias NameN/A

ClassificationBiologics > Blood components

Mechanisms of ActionErythropoietin receptor modulators

TargetsErythropoietin receptor

Therapy Area/IndicationsRenal Insufficiency

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCytonet

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCytonet

Active IndicationsN/A

Inactive IndicationsRenal Insufficiency

ATC CodeN/A